Please join us for an in-depth update and discussion of European legal and regulatory life sciences developments for biotech, pharmaceutical and medical device companies.
Program topics will include:
- Navigating Orphan Drug Designations in the EU and U.S.: Recent Developments
- Update on the Changing EU Medical Device Regulatory and Enforcement Landscape
- Where Are We with the Proposed EU Data Protection Regulation and What is Its Impact on U.S. Life Sciences Companies?
- Update on Anti-Bribery Compliance Developments in the EU
- Mergers, Acquisitions and Divisional deals: EU Perspective
- Clinical Trials Roundtable Discussion
9:00 a.m. Registration
9:30 a.m. - 3:00 p.m. Program
Breakfast, lunch and refreshments will be served.
Click here to access the full agenda.
For more information or questions, please contact email@example.com.